GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (FRA:1S70) » Definitions » Price-to-Funds-From-Operations

Cartesian Therapeutics (FRA:1S70) Price-to-Funds-From-Operations : (As of Apr. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Cartesian Therapeutics Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Cartesian Therapeutics Business Description

Traded in Other Exchanges
Address
7495 New Horizon Way, Frederick, MD, USA, 21703
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.